Eye-Drops for Activation of DREADDs.
Eye-Drops for Activation of DREADDs.
复制标题
DOI:
10.3389/fncir.2017.00093
复制
发表时间:
2017
影响因子:
3.5
通讯作者:
Hattar S
中科院分区:
文献类型:
--
作者:
Keenan WT;Fernandez DC;Shumway LJ;Zhao H;Hattar S
Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) are an important tool for modulating and understanding neural circuits. Depending on the DREADD system used, DREADD-targeted neurons can be activated or repressed in vivo following a dose of the DREADD agonist clozapine-N-oxide (CNO). Because DREADD experiments often involve behavioral assays, the method of CNO delivery is important. Currently, the most common delivery method is intraperitoneal (IP) injection. IP injection is both a fast and reliable technique, but it is painful and stressful particularly when many injections are required. We sought an alternative CNO delivery paradigm, which would retain the speed and reliability of IP injections without being as invasive. Here, we show that CNO can be effectively delivered topically via eye-drops. Eye-drops robustly activated DREADD-expressing neurons in the brain and peripheral tissues and does so at the same dosages as IP injection. Eye-drops provide an easier, less invasive and less stressful method for activating DREADDs in vivo.
登录
查看更多内容
影响因子:
9.2
作者:
Milosavljevic, Nina;Cehajic-Kapetanovic, Jasmina;Procyk, Christopher A.;Lucas, Robert J.
通讯作者:
Lucas, Robert J.
DOI:
10.1073/pnas.0700293104
发表时间:
2007-03-20
影响因子:
11.1
作者:
Armbruster, Blaine N.;Li, Xiang;Roth, Bryan L.
通讯作者:
Roth, Bryan L.
影响因子:
7.6
作者:
Zhu, Hu;Pleil, Kristen E.;Roth, Bryan L.
通讯作者:
Roth, Bryan L.
DOI:
10.1126/science.1205295
发表时间:
2011-07-29
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Ray RS;Corcoran AE;Brust RD;Kim JC;Richerson GB;Nattie E;Dymecki SM
通讯作者:
Dymecki SM
影响因子:
4.4
作者:
Milosavljevic N;Allen AE;Cehajic-Kapetanovic J;Lucas RJ
通讯作者:
Lucas RJ